{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.agents/dendrix",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:additionalType": [
        "Command-line agent",
        "Plug-in"
      ],
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_2533"
        },
        {
          "@id": "edam:topic_2640"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/gr.120477.111"
      },
      "sc:description": "De novo Driver Exclusivity is an algorithm to discover mutated driver pathways in cancer using only mutation data. It finds sets of genes, domains, or nucleotides whose mutations exhibit both high coverage and high exclusivity in the analyzed samples.",
      "sc:featureList": [
        {
          "@id": "edam:operation_2425"
        },
        {
          "@id": "edam:operation_3562"
        },
        {
          "@id": "edam:operation_2497"
        }
      ],
      "sc:name": "Dendrix",
      "sc:operatingSystem": [
        "Mac",
        "Linux"
      ],
      "sc:softwareHelp": {
        "@id": "http://compbio.cs.brown.edu/projects/dendrix/"
      },
      "sc:url": "http://compbio.cs.brown.edu/projects/dendrix/"
    },
    {
      "@id": "https://doi.org/10.1101/gr.120477.111",
      "@type": "sc:CreativeWork"
    }
  ]
}